Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 18, 2000
Non-Hodgkin's lymphoma: long-term survivors and adverse effects
R Epelbaum
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Prolonged daily administration of oral etoposide in lymphoma following prior therapy with adriamycin, an ifosfamide-containing salvage combination, and intravenous etoposide
N Haim, M Ben-Shahar, R Epelbaum
Current Medicinal Chemistry
|
March 11, 2010
Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications
G Bar-Sela, R Epelbaum, M Schaffer
Cancer
|
November 1, 1984
Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, Adriamycin (doxorubicin), and mitomycin C (modified FAM)
N Haim, R Epelbaum, Y Cohen, et al.
Cancer Treatment Reports
|
April 1, 1986
Mitomycin, doxorubicin, and vinblastine as second-line chemotherapy in patients with advanced breast cancer
R Borovik, R Epelbaum, Y Cohen, et al.
American Journal of Clinical Oncology
|
February 20, 1999
Dexamethasone, cytarabine, ifosfamide, and cisplatin as salvage therapy in non-Hodgkin lymphoma
N Haim, K Drumea, R Epelbaum, et al.
Harefuah
|
October 1, 1985
[Hodgkin's disease in Northern Israel]
Y Cohen, N Haim, M Ben Shahar, et al.
The American Journal of Dermatopathology
|
October 3, 2006
Pleomorphic CD8+ small/medium size cutaneous T-cell lymphoma
Z Khamaysi, Y Ben-Arieh, R Epelbaum, et al.
Oncology
|
January 1, 1987
Treatment of advanced gastric cancer with DDP (cisplatin), adriamycin, and 5-fluorouracil (DAF)
R Epelbaum, N Haim, M Stein, et al.
Cancer
|
January 15, 1984
The value of serum copper levels in non-Hodgkin's lymphoma
Y Cohen, R Epelbaum, N Haim, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 18, 2000
Non-Hodgkin's lymphoma: long-term survivors and adverse effects
R Epelbaum
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Prolonged daily administration of oral etoposide in lymphoma following prior therapy with adriamycin, an ifosfamide-containing salvage combination, and intravenous etoposide
N Haim, M Ben-Shahar, R Epelbaum
Current Medicinal Chemistry
|
March 11, 2010
Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications
G Bar-Sela, R Epelbaum, M Schaffer
Cancer
|
November 1, 1984
Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, Adriamycin (doxorubicin), and mitomycin C (modified FAM)
N Haim, R Epelbaum, Y Cohen, et al.
Cancer Treatment Reports
|
April 1, 1986
Mitomycin, doxorubicin, and vinblastine as second-line chemotherapy in patients with advanced breast cancer
R Borovik, R Epelbaum, Y Cohen, et al.
American Journal of Clinical Oncology
|
February 20, 1999
Dexamethasone, cytarabine, ifosfamide, and cisplatin as salvage therapy in non-Hodgkin lymphoma
N Haim, K Drumea, R Epelbaum, et al.
Harefuah
|
October 1, 1985
[Hodgkin's disease in Northern Israel]
Y Cohen, N Haim, M Ben Shahar, et al.
The American Journal of Dermatopathology
|
October 3, 2006
Pleomorphic CD8+ small/medium size cutaneous T-cell lymphoma
Z Khamaysi, Y Ben-Arieh, R Epelbaum, et al.
Oncology
|
January 1, 1987
Treatment of advanced gastric cancer with DDP (cisplatin), adriamycin, and 5-fluorouracil (DAF)
R Epelbaum, N Haim, M Stein, et al.
Cancer
|
January 15, 1984
The value of serum copper levels in non-Hodgkin's lymphoma
Y Cohen, R Epelbaum, N Haim, et al.
Page
of 7